Alkem Laboratories Limited (ALKEM.BO)
INR 4835.45
(2.88%)
INR 4835.45
(2.88%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 26.61 Billion INR | 2.06% |
| 2022 | 26.07 Billion INR | -13.24% |
| 2021 | 30.05 Billion INR | 29.97% |
| 2020 | 23.12 Billion INR | 27.14% |
| 2019 | 18.18 Billion INR | 21.27% |
| 2018 | 14.99 Billion INR | 4.0% |
| 2017 | 14.42 Billion INR | 19.58% |
| 2016 | 12.06 Billion INR | 32.61% |
| 2015 | 9.09 Billion INR | 15.96% |
| 2014 | 7.84 Billion INR | 55.43% |
| 2013 | 5.04 Billion INR | 13.93% |
| 2012 | 4.42 Billion INR | 49.04% |
| 2011 | 2.97 Billion INR | 30.37% |
| 2010 | 2.27 Billion INR | 29.72% |
| 2009 | 1.75 Billion INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 FY | 26.61 Billion INR | 2.06% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 25.41 Billion INR | 0.0% |
| 2023 Q4 | 26.61 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 FY | 26.07 Billion INR | -13.24% |
| 2022 Q4 | 26.07 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 27.85 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q2 | 25.27 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 30.05 Billion INR | 29.97% |
| 2021 Q4 | 30.05 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 23.12 Billion INR | 0.0% |
| 2020 Q2 | 19.81 Billion INR | 0.0% |
| 2020 FY | 23.12 Billion INR | 27.14% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 18.18 Billion INR | 0.0% |
| 2019 Q2 | 16.21 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 FY | 18.18 Billion INR | 21.27% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q4 | 14.99 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 FY | 14.99 Billion INR | 4.0% |
| 2018 Q2 | 14.43 Billion INR | 0.0% |
| 2017 Q4 | 14.42 Billion INR | 0.0% |
| 2017 FY | 14.42 Billion INR | 19.58% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q2 | 11.16 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 FY | 12.06 Billion INR | 32.61% |
| 2016 Q2 | 9.62 Billion INR | 0.0% |
| 2016 Q4 | 12.06 Billion INR | 0.0% |
| 2015 Q2 | 8.5 Billion INR | 0.0% |
| 2015 Q4 | 9.09 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 9.09 Billion INR | 15.96% |
| 2014 Q4 | 7.84 Billion INR | 0.0% |
| 2014 FY | 7.84 Billion INR | 55.43% |
| 2014 Q1 | - INR | 0.0% |
| 2013 FY | 5.04 Billion INR | 13.93% |
| 2012 FY | 4.42 Billion INR | 49.04% |
| 2011 FY | 2.97 Billion INR | 30.37% |
| 2010 FY | 2.27 Billion INR | 29.72% |
| 2009 FY | 1.75 Billion INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | -61.918% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 72.868% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | -299.222% |
| Granules India Limited | 13 Billion INR | -104.62% |
| Indoco Remedies Limited | 3.53 Billion INR | -653.747% |
| Achyut Healthcare Limited | 568 Thousand INR | -4685076.056% |
| Ajanta Pharma Limited | 8.28 Billion INR | -221.259% |
| Alpa Laboratories Limited | 136.65 Million INR | -19373.996% |
| Brooks Laboratories Limited | 96.1 Million INR | -27589.474% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -1067.789% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -1747.552% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -2146.721% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 58.126% |
| Eris Lifesciences Limited | 1.89 Billion INR | -1307.793% |
| FDC Limited | 3.88 Billion INR | -584.304% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | -5.894% |
| Gufic Biosciences Limited | 2 Billion INR | -1227.39% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -25347.087% |
| Ipca Laboratories Limited | 24.71 Billion INR | -7.683% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -17644.749% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -27064.877% |
| Lasa Supergenerics Limited | 190.43 Million INR | -13874.29% |
| Laurus Labs Limited | 18.45 Billion INR | -44.205% |
| Lupin Limited | 49.53 Billion INR | 46.281% |
| Mankind Pharma Limited | 15.53 Billion INR | -71.306% |
| Medicamen Biotech Limited | 593.75 Million INR | -4381.972% |
| Medico Remedies Limited | 163.37 Million INR | -16189.083% |
| Megasoft Limited | - INR | -Infinity% |
| NATCO Pharma Limited | 7 Billion INR | -279.897% |
| Piramal Pharma Limited | 21.75 Billion INR | -22.304% |
| RPG Life Sciences Limited | 1.01 Billion INR | -2534.832% |
| Sigachi Industries Limited | 707.2 Million INR | -3662.944% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 73.033% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -1051.051% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -12523.295% |
| Unichem Laboratories Limited | 7.04 Billion INR | -277.646% |
| Wanbury Limited | 360.23 Million INR | -7287.406% |
| Windlas Biotech Limited | 621.89 Million INR | -4179.181% |
| ZIM Laboratories Limited | 812.62 Million INR | -3174.779% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 22.683% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Divi's Laboratories Limited | 31.84 Billion INR | 16.42% |
| Hester Biosciences Limited | 755.81 Million INR | -3420.964% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -2338.988% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -9106.738% |
| Bal Pharma Limited | 878.11 Million INR | -2930.563% |
| Strides Pharma Science Limited | 11.26 Billion INR | -136.289% |
| Venus Remedies Limited | 1.21 Billion INR | -2086.852% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | -313.959% |
| Nectar Lifesciences Limited | 7.09 Billion INR | -275.263% |
| Shilpa Medicare Limited | 3.44 Billion INR | -671.517% |
| Aarti Drugs Limited | 4.85 Billion INR | -447.692% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | -526.396% |
| Suven Life Sciences Limited | 7.08 Million INR | -375507.622% |
| Ind-Swift Limited | 640.91 Million INR | -4052.157% |
| Valiant Laboratories Limited | 100.15 Million INR | -26470.881% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | -429.578% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | -639.833% |
| Themis Medicare Limited | 705.74 Million INR | -3670.749% |
| Hikal Limited | 3.03 Billion INR | -776.195% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | -16.77% |
| Sequent Scientific Limited | 3.46 Billion INR | -668.612% |
| Novartis India Limited | 448.6 Million INR | -5832.189% |
| Wockhardt Limited | 6.4 Billion INR | -315.809% |
| Jubilant Pharmova Limited | 12.89 Billion INR | -106.357% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -104272.279% |
| Neuland Laboratories Limited | 3.5 Billion INR | -659.422% |
| Morepen Laboratories Limited | 2.48 Billion INR | -970.492% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -66629.689% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -2052.365% |